반응형
Global Data Intelligence Center | ||
구분 | 보고서 (영문) | 업로드 날짜 |
제약/바이오/임상시험 | Keytruda Wins Second Place in the Race to Approval for Neo-adjuvant NSCLC | 10-20-2023 |
Manufacturing Issues Delay Lebrikizumab’s Entry to the Atopic Dermatitis Market | 10-23-2023 | |
Pear Therapeutics: A Lesson for Future DTx Developers | 10-23-2023 | |
Opdivo’s Additional FDA Nod Continues the Battle of Immune Checkpoint Inhibitors | 10-23-2023 | |
AnapstysBio’s Imsidolimab Phase III Trial’s Promising Results Can Bring it Closer to Marketing Approval | 10-25-2023 | |
Venture Financing for Targeted Protein Degraders Soars in 2022 | 10-27-2023 | |
North America Leads Dose Response Trials | 10-30-2023 | |
Upcoming Breast Cancer Trials in China | 10-31-2023 | |
Tibsovo Unlocks a New Era for Rare Blood Cancers Called Myelodysplastic Syndromes | 10-31-2023 | |
US Meningococcal Vaccines Market to Begin to Shift Towards Pentavalent Vaccines | 11-02-2023 | |
질환별 | Neuronopathic Therapies Are a Serious Unmet Need in the Treatment of Gaucher Disease | 10-18-2023 |
Red Meat Consumption Linked to Elevated Type 2 Diabetes Rate | 10-23-2023 | |
Antimicrobial Resistance Threatens to Set Modern Medicine Back Decades | 10-24-2023 | |
Finding the Crohn’s Disease Leader Is Underway with the Anti-Interleukin 23s | 10-25-2023 | |
Myasthenia Gravis: Opportunity Assessment and Forecast | 10-31-2023 | |
컨퍼런스/ 심포지엄/학회 |
ESMO 2023: Mirati’s Krazati and Immuno-oncology Combination to Shape KRAS-mutated First-Line NSCLC Landscape | 10-23-2023 |
ESMO 2023: MSD’s Welireg Sets the Stage for HIF-2alpha Inhibitors in Clear Cell RCC Despite Unclear OS | 10-23-2023 | |
ESMO 2023: Astellas’s Padcev Combo Disrupts Urothelial Cancer Landscape with EV-302 Results | 11-02-2023 | |
Highlights from the ESMO 2023 Congress: Antibody-Drug Conjugates and Bispecific T-cell Engagers | 11-02-2023 |
반응형
'의료기기관련기관 > 국가임상시험지원재단' 카테고리의 다른 글
[KoNECT] 해외 임상시험 정보 데이터(Global Data) 보고서 업데이트 안내 (0) | 2024.01.08 |
---|---|
[KoNECT] 해외 임상시험 정보 데이터(Global Data) 보고서 업데이트 안내 (0) | 2023.11.29 |
[국가임상시험지원재단] 해외 임상시험 정보 데이터(Global Data) 보고서 (0) | 2023.11.29 |
[국가임상시험지원재단] 해외 임상시험 정보 데이터(Global Data) 보고서 (0) | 2023.11.29 |
<Vendor 기업 주력 사업 조사> (0) | 2023.10.06 |